Grønlandsbanken A/S
19.3.2021 20:24:32 CET | Globenewswire | Press release
To Nasdaq OMX Copenhagen
19 March 2021
Company Announcement No 05/2021
Announcement of the granting of Power of Attorney to the Board of Directors
Pursuant to announcement no 1172 of 31 October 2017 regarding Major Shareholders, The BANK of Greenland hereby announces, that the Board of Directors have received unqualified Powers of Attorney for use on The BANK of Greenland’s ordinary general meeting March 24, 2021, representing 31.93 percent of the company’s share capital, or 574,800 shares.
24 March 2021 upon termination of the ordinary general meeting, the right of the Board of Director’s to vote in accordance with the Powers of Attorney granted shall cease.
For further information, please contact:
The BANK of Greenland
Martin Kviesgaard
Managing Director
Telephone: +299 34 78 02
E-mail: mbk@banken.gl
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Danske Bank A/S29.10.2026 12:30:23 CET | Press release
Danske Bank A/S, transactions by persons discharging managerial responsibilities
Danske Bank A/S29.10.2026 12:30:23 CET | Pressemeddelelse
Danske Bank A/S, ledende medarbejderes transaktioner
Junshi Biosciences29.10.2026 12:04:40 CET | Press release
Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma
Minerva Neurosciences, Inc29.10.2026 12:00:00 CET | Press release
Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London
Sironax USA, Inc.29.10.2026 12:00:00 CET | Press release
Sironax Announces Three Abstracts on SARM1 Inhibitor SIR2501 Selected for Presentation at Neuroscience 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
